AEYE Health
PrivateLast Round
Crowdfunding
Nov 8, 2023
Est. Valuation
$52.08M
Total Funding Raised
$11.32M
Company Overview
AEYE Health operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Crowdfunding round in November 2023.
AEYE Health is a health tech company that provides a fully autonomous, AI-based diagnostic screening technology for retinal imaging to detect conditions like diabetic retinopathy.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AEYE Health Comparables
Compare AEYE Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RETINA-AI Health | 91% | |
| Digital Diagnostics | 89% | |
| Eyenuk | 88% |
For institutional investors. Book with your work email.
AEYE Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Nov 8, 2023 | ||||
| Series C | May 22, 2022 | ||||
| Seed | Jan 1, 2022 | ||||
| Seed | Mar 21, 2021 | ||||
| Accelerator | Jan 15, 2020 | ||||
Accelerator | Nov 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AEYE Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Florida-Israel Business Accelerator | Accelerator |
| Club 100 Plus | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
Added Wolfecomms, a healthcare SMB, as a customer.
- Sep 4, 2025
Yonatan Raz-Fridman joins to lead U.S. market expansion.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 4, 2026
AEYE Health Inc. is developing AEYE-X, an investigational AI-based oculomics platform designed to assess more than 100 cardiovascular, metabolic, neurological, and ocular health indications using retinal images, as reported on Nov 4th '26.
- recognized_asNov 3, 2026
TIME names AEYE Health Inc. CEO Dr. Zack Dvey-Aharon among its 100 Most Influential People in AI in 2024, while he describes receiving the Prix Galien Award as one of the greatest honors of his professional life.
- receives_awardNov 3, 2026
AEYE Health Inc. receives the 2026 Prix Galien USA Award for Best Digital Health Solution for its FDA-cleared AEYE-DS technology, which makes sight-saving diabetic eye exams accessible at virtually any point of care, in New York on Nov 3rd '26.
- attends_eventAug 18, 2026
AEYE Health Inc. exhibits at the 2026 National Tribal Health Conference from Aug 16–21, '26, in Arizona, showcasing its work in community eye care.
For institutional investors. Book with your work email.
AEYE Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AEYE Health's valuation, stock price, and market status.
Is AEYE Health a public or private company?
AEYE Health is a private company.
What is the current stock price of AEYE Health?
AEYE Health is a private company, so its shares have no public market price. Caplight tracks AEYE Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AEYE Health worth (valuation)?
AEYE Health's valuation is estimated at $52.1M based on funding round data.
Can I buy AEYE Health stock?
AEYE Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AEYE Health's last funding round?
AEYE Health's most recent funding round was Crowdfunding on November 8, 2023.
Who are the main investors in AEYE Health?
Key investors in AEYE Health include Florida-Israel Business Accelerator, Club 100 Plus.
Will AEYE Health IPO soon?
No public IPO plans have been announced for AEYE Health.
How can I track AEYE Health secondary market activity?
Caplight tracks bids, offers, and trades in AEYE Health's shares on secondary markets.